136 related articles for article (PubMed ID: 7761100)
1. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis.
Kondo S; Barnett GH; Hara H; Morimura T; Takeuchi J
Oncogene; 1995 May; 10(10):2001-6. PubMed ID: 7761100
[TBL] [Abstract][Full Text] [Related]
2. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.
Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH
Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material.
Bell HS; Whittle IR; Bader SA; Wharton SB
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):191-202. PubMed ID: 15771712
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1.
Sato N; Mizumoto K; Maehara N; Kusumoto M; Nishio S; Urashima T; Ogawa T; Tanaka M
Anticancer Res; 2000; 20(2A):837-42. PubMed ID: 10810363
[TBL] [Abstract][Full Text] [Related]
6. Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.
Prasad G; Wang H; Agrawal S; Zhang R
Anticancer Res; 2002; 22(1A):107-16. PubMed ID: 12017271
[TBL] [Abstract][Full Text] [Related]
7. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
8. Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation.
Mahdi T; Alcalay D; Cognard C; Tanzer J; Kitzis A
Biol Cell; 1998 Dec; 90(9):615-27. PubMed ID: 10085538
[TBL] [Abstract][Full Text] [Related]
9. mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line.
Kondo S; Kondo Y; Hara H; Kaakaji R; Peterson JW; Morimura T; Takeuchi J; Barnett GH
Br J Cancer; 1996 Oct; 74(8):1263-8. PubMed ID: 8883415
[TBL] [Abstract][Full Text] [Related]
10. Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53.
Sun NK; Huang SL; Chien KY; Chao CC
Biochem J; 2012 Jun; 444(2):303-14. PubMed ID: 22397410
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression.
Chen L; Lu W; Agrawal S; Zhou W; Zhang R; Chen J
Mol Med; 1999 Jan; 5(1):21-34. PubMed ID: 10072445
[TBL] [Abstract][Full Text] [Related]
12. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor efficacy of a novel antisense anti-MDM2 mixed-backbone oligonucleotide in human colon cancer models: p53-dependent and p53-independent mechanisms.
Wang H; Nan L; Yu D; Lindsey JR; Agrawal S; Zhang R
Mol Med; 2002 Apr; 8(4):185-99. PubMed ID: 12149568
[TBL] [Abstract][Full Text] [Related]
15. Mdm2 sensitizes MCF7 breast cancer cells to cisplatin or carboplatin.
Smith ML
Breast Cancer Res Treat; 1999 Nov; 58(2):99-105. PubMed ID: 10674873
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage.
Chen L; Agrawal S; Zhou W; Zhang R; Chen J
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):195-200. PubMed ID: 9419352
[TBL] [Abstract][Full Text] [Related]
17. Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line.
Grünbaum U; Meye A; Bache M; Bartel F; Würl P; Schmidt H; Dunst J; Taubert H
Anticancer Res; 2001; 21(3B):2065-71. PubMed ID: 11497299
[TBL] [Abstract][Full Text] [Related]
18. P53 regulation of leukemia cells with the blockage of MDM2 by antisense oligonucleotides.
Fang M; Ji X; Tang Y; Liu W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):414-6. PubMed ID: 17120736
[TBL] [Abstract][Full Text] [Related]
19. Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin.
Siemer S; Ornskov D; Guerra B; Boldyreff B; Issinger OG
Int J Biochem Cell Biol; 1999 Jun; 31(6):661-70. PubMed ID: 10404639
[TBL] [Abstract][Full Text] [Related]
20. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
